CN102488834B - Medicament for treating acute upper respiratory tract infection - Google Patents

Medicament for treating acute upper respiratory tract infection Download PDF

Info

Publication number
CN102488834B
CN102488834B CN 201110410284 CN201110410284A CN102488834B CN 102488834 B CN102488834 B CN 102488834B CN 201110410284 CN201110410284 CN 201110410284 CN 201110410284 A CN201110410284 A CN 201110410284A CN 102488834 B CN102488834 B CN 102488834B
Authority
CN
China
Prior art keywords
weight portion
weight
respiratory tract
medicament
tract infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201110410284
Other languages
Chinese (zh)
Other versions
CN102488834A (en
Inventor
张永扬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201110410284 priority Critical patent/CN102488834B/en
Publication of CN102488834A publication Critical patent/CN102488834A/en
Application granted granted Critical
Publication of CN102488834B publication Critical patent/CN102488834B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a medicament for treating acute upper respiratory tract infection, which is prepared by pseudo-ginseng, sword bean, forsythia suspense, tangerine peel, achyranthes bidentata, euchresta japonica, eucommia, folium isatidis, honeysuckle, rhubarb, polygala tenuifolia, wild ginger, lilium brownii, cowherb seed and herba hyperici. The medicament for treating the acute upper respiratory tract infection is reasonable in prescription and remarkable in curative effect and has no obvious side-effect. In addition, components are simple and easy to obtain.

Description

A kind of medicament for the treatment of acute upper respiratory tract infection
Technical field
The present invention relates to field of medicaments, particularly, the present invention relates to a kind of medicament that is used for the treatment of acute upper respiratory tract infection.
Background technology
Acute upper respiratory tract infection is the general title of nasal cavity, pharynx or acute throat inflammation.The commonly encountered diseases substance is virus, and minority is antibacterial.Its no age of morbidity, sex, occupation and regional difference.The general state of an illness is lighter, and the course of disease is shorter, the prognosis bona.But because the sickness rate height has certain infectiousness, not only influence input of labor, also can produce severe complication sometimes, should actively prevent and treat.Primary disease all can be fallen ill the whole year, but occurred frequently with winter-spring season, can mostly be and distribute by the spittle or contaminated hands and the apparatus propagation that contains virus, but can be popular when abrupt change of climate.
Summary of the invention
The purpose of this invention is to provide a kind of medicament that is used for the treatment of acute upper respiratory tract infection.
In order to realize purpose of the present invention, the invention provides a kind of medicament that is used for the treatment of acute upper respiratory tract infection, it is the medicament of being made according to weight proportion by following ingredients:
Figure BSA00000633247300011
Preferably, the medicament for acute upper respiratory tract infection of the present invention is the medicament of being made according to weight proportion by following ingredients:
Figure BSA00000633247300012
Figure BSA00000633247300021
Pharmacy optimization for acute upper respiratory tract infection of the present invention can be made into tablet (dispersible tablet), capsule, (hard capsule), granule etc.
Reagent combination for acute upper respiratory tract infection of the present invention is reasonable, and composition is simple and easy to, and is evident in efficacy, and do not have significant side effects.
The specific embodiment
The following examples will give further instruction to the present invention, but not thereby limiting the invention.
Embodiment 1 granule of the present invention
Get Radix Notoginseng 5 grams, Semen Canavaliae 3 grams, Fructus Forsythiae 15 grams, Pericarpium Citri Reticulatae 5 grams, Radix Achyranthis Bidentatae 3 grams, Radix Sophorae Tonkinensis 5 grams, the Cortex Eucommiae 10 grams, Folium Isatidis 5 grams, Flos Lonicerae 5 grams, Radix Et Rhizoma Rhei 10 grams, Radix Polygalae 20 grams, Herba Asari 5 grams, Bulbus Lilii 10 grams, Semen Vaccariae 3 grams, Herba Hyperici 5 grams, pulverized 80 mesh sieves, add Icing Sugar 50 grams, mannitol 80 gram mix homogeneously, with 8% amidin soft material processed, pelletize, divide in the bag of packing into every bag 20 gram.
The test example
Select emergency treatment acute upper respiratory tract infection patient 50 examples, male 25 examples wherein, women 25 examples, minimal ages 18 years old, maximum 56 years old age.Include standard in: 1. meet relevant " acute upper respiratory tract infection hyperpyrexia " diagnostic criteria (Wu Shaozhen in " diagnosis of common disease and curative effect determinate standard ", Wu Min. the diagnosis of common disease and curative effect determinate standard [M]. Beijing: China Traditional Chinese Medicine Publishing House, 1999:140-142.): onset is anxious, inducement such as suffer from cold, overworked or with respiratory tract infection patient contact history; Clinical symptoms can show as cough, expectorant is the amount doesn't matter, pharyngalgia, general pain, nasal obstruction, watery nasal discharge, hoarseness; Axillaty temperature is more than 38.5 ℃; The two lung auscultation respiratory murmurs of having a medical check-up are normal or increase thick or audible and dried, moist rales.Chest X-ray shows normal or enhanced lung markings.2. fall ill in 72h.3. the age is more than 14 years old or below 70 years old.4. there is not the medication contraindication.5. be not associated with cardiovascular and cerebrovascular disease and serious hepatorenal disease.6. patient's informed consent.
Therapeutic Method:
Use the granule of embodiment 1 preparation to treat every day 3 times, each 1 bag.
Be a course for the treatment of for three days on end.
The clinical recovery criterion:
Meet " diagnosis of common disease and curative effect determinate standard " (Wu Shaozhen, Wu Min. the diagnosis of common disease and curative effect determinate standard [M]. Beijing: China Traditional Chinese Medicine Publishing House, 1999:140-142.), that is: 1. produce effects: in the 24h, cardinal symptoms such as General Symptoms and local pyrexia, cough, pharyngalgia disappear or basic the disappearance after the medication; 2. effective: in the medication 24-48h, cardinal symptoms such as General Symptoms and local pyrexia, cough, pharyngalgia disappear or basic the disappearance; 3. invalid: do not meet above standard person all be considered as invalid.
The result:
After treating a course for the treatment of, all patients all meet the standard of produce effects.

Claims (1)

1. a medicament that is used for the treatment of acute upper respiratory tract infection is characterized in that, it is to be made according to weight proportion by following ingredients:
Radix Notoginseng 5 weight portion Semen Canavaliaes 3 weight portion Fructus Forsythiaes 15 weight portions
Pericarpium Citri Reticulatae 5 weight portion Radix Achyranthis Bidentataes 3 weight portion Radix Sophorae Tonkinensiss 5 weight portions
The Cortex Eucommiae 10 weight portion Folium Isatidiss 5 weight portion Flos Loniceraes 5 weight portions
Radix Et Rhizoma Rhei 10 weight portion Radix Polygalaes 20 weight portion Herba Asaris 5 weight portions
Bulbus Lilii 10 weight portion Semen Vaccariae 3 weight portion Herba Hypericis 5 weight portions.
CN 201110410284 2011-12-12 2011-12-12 Medicament for treating acute upper respiratory tract infection Expired - Fee Related CN102488834B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110410284 CN102488834B (en) 2011-12-12 2011-12-12 Medicament for treating acute upper respiratory tract infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110410284 CN102488834B (en) 2011-12-12 2011-12-12 Medicament for treating acute upper respiratory tract infection

Publications (2)

Publication Number Publication Date
CN102488834A CN102488834A (en) 2012-06-13
CN102488834B true CN102488834B (en) 2013-08-14

Family

ID=46180732

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110410284 Expired - Fee Related CN102488834B (en) 2011-12-12 2011-12-12 Medicament for treating acute upper respiratory tract infection

Country Status (1)

Country Link
CN (1) CN102488834B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857707A (en) * 2006-03-16 2006-11-08 李玉海 Chinese medicine mixture for treating infantile dyspneic cough

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200281A (en) * 1997-05-28 1998-12-02 王治立 Heatlh-care medicinal liquor
CN1380098A (en) * 2002-05-20 2002-11-20 张勇飞 Anti-infection compound preparation and its preparation method
CN101816757B (en) * 2010-06-02 2012-04-18 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating antiaditis and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857707A (en) * 2006-03-16 2006-11-08 李玉海 Chinese medicine mixture for treating infantile dyspneic cough

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
中草药在防治畜禽呼吸道病毒病上的应用前景;刘海燕等;《畜牧与饲料科学》;20100831;第31卷(第08期);103-106 *
刘海燕等.中草药在防治畜禽呼吸道病毒病上的应用前景.《畜牧与饲料科学》.2010,第31卷(第08期),103-106.
抗病毒中草药研究进展;蒋锡源;《药学实践杂志》;19891231;第7卷(第03期);71-74 *
抗病毒中草药研究进展;褚秀玲等;《中兽医学杂志》;20060225(第01期);33-38 *
蒋锡源.抗病毒中草药研究进展.《药学实践杂志》.1989,第7卷(第03期),71-74.
褚秀玲等.抗病毒中草药研究进展.《中兽医学杂志》.2006,(第01期),33-38.

Also Published As

Publication number Publication date
CN102488834A (en) 2012-06-13

Similar Documents

Publication Publication Date Title
Lee et al. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
CN105055606A (en) Medicine for treating influenza
CN104147424A (en) Traditional Chinese medicine for treating bronchial asthma
CN101897879B (en) Traditional Chinese medicine for treating rheumatic arthritis
CN104940485A (en) Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof
CN102091268A (en) Medicament for treating allergic rhinitis and preparation method thereof
CN101953949B (en) Chinese medicinal composition for treating allergic rhinitis
CN103142982A (en) Medicine for treating acute upper respiratory infection
CN103845617B (en) One treats invisible brightic medicament
CN102091296B (en) Medicament for treating breast hyperplasia
CN102488834B (en) Medicament for treating acute upper respiratory tract infection
CN105125838A (en) Traditional Chinese medicine composite for treating infantile asthma and preparing method thereof
CN102205096A (en) Medicament for treating adnexitis and pelvic inflammation
CN105327182A (en) Medicine for treating child pertussis and preparation method thereof
CN103110910B (en) Agent for treating acute upper respiratory infection
CN103417809A (en) TCM preparation for treatment of thrush in infants and children
CN107582834A (en) A kind of Chinese medicine composition for treating empty asthma
CN103083524A (en) Traditional Chinese medicine granules used for treating chicken aspergillosis, and preparation method thereof
CN101829213B (en) Medicine composition for treating asthma and preparation method thereof
CN101884704B (en) Traditional Chinese medicine for treating asthma
CN104825838B (en) A kind of medicine for the treatment of acute upper respiratory tract infection
CN105168860A (en) Traditional Chinese medicine composite for treating infantile asthma and preparation method thereof
CN103655875B (en) Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis
CN105362548A (en) Traditional Chinese medicine for treating allergic asthma
CN102973803A (en) Drug for treating hematopathy primary thrombocytopenic purpura

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130814

Termination date: 20161212